Other cancer risk-associated CHEK2 variants have been reported [22], some of which in ethnically defined groups such as the Ashkenazi Jewish population [25], suggesting the influence of founder effects underlying CHEK2 mutational spectra. The gene discussed is CHEK2; the disease is cancer.